Investors

Market Opportunity/Potential

  • HEATT market has potential applications for all solid metastatic cancers (estimated at 324k+ new cases in the US annually each with multiple treatment cycles)
  • The market size of radiation is a $4.4B industry, growing at 5.3%/year
  • Chemotherapy is estimated to reach $93B by 2016, growing at 8%/year.
  • Overall US market for oncology will grow to $158B by 2020.

HEATT Total Market Opportunity is 900,000 procedures/year!

Strategic Advantages Over Other Technologies

  • HEATT is a complement modality to:
    • Surgery
    • Radiation
    • Chemotherapy
  • Abdominal cavity hyperthermia is well accepted, but has limited scope. Currently in 160 top medical centers.
  • A few European firms have introduced non-effective, externally induced hyperthermia with no clinical data and ambiguous success due to poor therapeutic controls.

For more information about Verthermia, please submit the form below.

Name (required)

Email (required)

Topic

Type of Customer

How Did You Hear About Us? (required)

Company

Phone (xxx-xxx-xxxx)

City (required)

State

Country (required)

Message

Please leave this field empty.